Pharmacotherapy of acute respiratory distress syndrome.


To date, the only therapeutic option that has convincingly been shown to decrease mortality in acute respiratory distress syndrome (ARDS) has been to use a lung-protective strategy that minimises the iatrogenic consequences of providing adequate life support through the use of mechanical ventilation. In terms of the pharmacological options for ARDS, no… (More)


Cite this paper

@article{Santos2002PharmacotherapyOA, title={Pharmacotherapy of acute respiratory distress syndrome.}, author={C. C. dos Santos and C Chant and A. S. Slutsky}, journal={Expert opinion on pharmacotherapy}, year={2002}, volume={3 7}, pages={875-88} }